Latest article: |
|
|
Recent articles: |
|
First Isolation of Full-Length BRCA2 Protein to Assist in Ovarian and Breast Cancer Research
01 Sep 2010: Using Bio-Rad Mini-PROTEAN® TGX™ Precast Gels, Dr Ryan Jensen of the University of California, Davis and colleagues report the first purification of full-length BRCA2 protein. Proper study of the product of the BRCA2 gene, mutations of which lead to breast and ovarian cancers, has eluded research groups for years due to challenges preventing its purification.
Bio-Rad Laboratories, Inc.
|
QIAsymphony RGQ® Sets New Standards for Molecular Testing
01 Sep 2010: The QIAsymphony RGQ® from QIAGEN is a novel and flexible automated system for molecular testing, incorporating all workflow steps from sample to detection. This new and complete workflow solution is comprised of modules that can be used as stand-alone systems or combined into a fully integrated system.
QIAGEN
|
New Resource for Evaporative Sample Preparation
 01 Sep 2010: Genevac presents a new web-resource that brings together the latest technological innovations, applications advances and links to references that detail the current scope of evaporative sample preparation techniques as used in clinical and diagnostic testing which improve efficiency and data quality in the laboratory.
Genevac
|
Exhibitors Confident in the Run-Up to BIOTECHNICA 2010
31 Aug 2010: The biotech industry is setting its sights on Hannover, where exhibitors and visitors from all over the world will convene this autumn at BIOTECHNICA 2010 from 5 to 7 October. A plethora of small, highly specialized firms will exhibit in Hannover alongside numerous companies and industry leaders, including Eppendorf, Qiagen, Sartorius and Thermo Fisher Scientific.
Deutsche Messe AG
|
New Live Cell-Impermeant Far-Red Fluorescing DNA Dye
 27 Aug 2010: The new DRAQ7™ from Biostatus Ltd. is a new live cell-impermeant far-red fluorescing DNA dye with the spectral properties that made DRAQ5™ a reagent of choice. For flow cytometry applications, DRAQ7™ rapidly labels only dead, dying and apoptotic cells in cytotoxicity and viability assays, as well as fixed cell preparations. Its far-red emission permits new combinations of dyes to be used in the understanding of apoptosis.
Biostatus Limited
|
VLife Sciences Announces Two Novel Methods Which Enable New Molecule Design and Lead Optimization
 27 Aug 2010: GQSAR and VLifeSCOPE from VLife Sciences enables new molecule design and lead optimization using a combination of residual interaction protein ligand studies & fragment based QSAR based approach. GQSAR offers flexibility to study molecular fragments of interest in relation to the variation in biological response. VLifeSCOPE helps to identify key residues in the active site that are involved in modulating the activity of a series of molecules.
VLife Sciences Technologies Pvt. Ltd.
|
Standardized Comet Assay System Ensures Reproducible Cancer Research Results
 26 Aug 2010: The CometAssay® Electrophoresis System and new CometAssay® Neutral Control cells from AMSBIO enable investigators to consistently optimize neutral Comet assays for highly reproducible results, and to standardize neutral electrophoresis methods between individual users and laboratories.
AMSBIO
|
High-Throughput Melt Curve Analysis for Verification and Genotyping of SNPs in 4 Alaska Populations of Chum Salmon
25 Aug 2010: This application poster describes how the BioMark™ System and 96.96 Dynamic Array™ Integrated Fluidic Circuit (IFC) has been used by the University of Washington for verification and genotyping of SNP's in Alaskan populations of Chum Salmon.
Fluidigm Corporation
|
ChanTest Introduces New Ion Channel and GPCR Assays for Drug Discovery and Preclinical Safety at ELRIG 2010
 25 Aug 2010: ChanTest will be featuring new ion channel and GPCR cell-based assays for screening and profiling, along with additions to the company’s leading preclinical cardiac safety services. For drug discovery, the company has recently introduced cost-effective, transiently-transfected EZCells™ reagents for ion channel profiling and CNG-mediated (cyclic nucleotide-gated) cAMP assays for GPCRs.
ChanTest Corporation
|
